186 related articles for article (PubMed ID: 10524630)
21. Integrin activates receptor-like protein tyrosine phosphatase alpha, Src, and Rho to increase prolactin gene expression through a final phosphatidylinositol 3-kinase/cytoskeletal pathway that is additive with insulin.
Vulin AI; Jacob KK; Stanley FM
Endocrinology; 2005 Aug; 146(8):3535-46. PubMed ID: 15878970
[TBL] [Abstract][Full Text] [Related]
22. Receptor protein tyrosine phosphatase alpha activates Src-family kinases and controls integrin-mediated responses in fibroblasts.
Su J; Muranjan M; Sap J
Curr Biol; 1999 May; 9(10):505-11. PubMed ID: 10339427
[TBL] [Abstract][Full Text] [Related]
23. Expression of tetraspan protein CD63 activates protein-tyrosine kinase (PTK) and enhances the PTK-induced inhibition of ROMK channels.
Lin D; Kamsteeg EJ; Zhang Y; Jin Y; Sterling H; Yue P; Roos M; Duffield A; Spencer J; Caplan M; Wang WH
J Biol Chem; 2008 Mar; 283(12):7674-81. PubMed ID: 18211905
[TBL] [Abstract][Full Text] [Related]
24. Clustering of phosphatase RPTPα promotes Src signaling and the arthritogenic action of synovial fibroblasts.
Sendo S; Kiosses WB; Yang S; Wu DJ; Lee DWK; Liu L; Aschner Y; Vela AJ; Downey GP; Santelli E; Bottini N
Sci Signal; 2023 Jul; 16(792):eabn8668. PubMed ID: 37402225
[TBL] [Abstract][Full Text] [Related]
25. Dimerization-induced inhibition of receptor protein tyrosine phosphatase function through an inhibitory wedge.
Majeti R; Bilwes AM; Noel JP; Hunter T; Weiss A
Science; 1998 Jan; 279(5347):88-91. PubMed ID: 9417031
[TBL] [Abstract][Full Text] [Related]
26. Multimerization of the protein-tyrosine phosphatase (PTP)-like insulin-dependent diabetes mellitus autoantigens IA-2 and IA-2beta with receptor PTPs (RPTPs). Inhibition of RPTPalpha enzymatic activity.
Gross S; Blanchetot C; Schepens J; Albet S; Lammers R; den Hertog J; Hendriks W
J Biol Chem; 2002 Dec; 277(50):48139-45. PubMed ID: 12364328
[TBL] [Abstract][Full Text] [Related]
27. Redox-regulated rotational coupling of receptor protein-tyrosine phosphatase alpha dimers.
van der Wijk T; Blanchetot C; Overvoorde J; den Hertog J
J Biol Chem; 2003 Apr; 278(16):13968-74. PubMed ID: 12582170
[TBL] [Abstract][Full Text] [Related]
28. Serine dephosphorylation of receptor protein tyrosine phosphatase alpha in mitosis induces Src binding and activation.
Vacaru AM; den Hertog J
Mol Cell Biol; 2010 Jun; 30(12):2850-61. PubMed ID: 20385765
[TBL] [Abstract][Full Text] [Related]
29. Association between receptor protein-tyrosine phosphatase RPTPalpha and the Grb2 adaptor. Dual Src homology (SH) 2/SH3 domain requirement and functional consequences.
Su J; Yang LT; Sap J
J Biol Chem; 1996 Nov; 271(45):28086-96. PubMed ID: 8910422
[TBL] [Abstract][Full Text] [Related]
30. SH2 domain-mediated interaction of inhibitory protein tyrosine kinase Csk with protein tyrosine phosphatase-HSCF.
Wang B; Lemay S; Tsai S; Veillette A
Mol Cell Biol; 2001 Feb; 21(4):1077-88. PubMed ID: 11158295
[TBL] [Abstract][Full Text] [Related]
31. Structural basis for inhibition of receptor protein-tyrosine phosphatase-alpha by dimerization.
Bilwes AM; den Hertog J; Hunter T; Noel JP
Nature; 1996 Aug; 382(6591):555-9. PubMed ID: 8700232
[TBL] [Abstract][Full Text] [Related]
32. CD45 and RPTPalpha display different protein tyrosine phosphatase activities in T lymphocytes.
Ng DH; Jabali MD; Maiti A; Borodchak P; Harder KW; Brocker T; Malissen B; Jirik FR; Johnson P
Biochem J; 1997 Nov; 327 ( Pt 3)(Pt 3):867-76. PubMed ID: 9581568
[TBL] [Abstract][Full Text] [Related]
33. Expression of protein tyrosine phosphatase alpha (RPTPalpha) in human breast cancer correlates with low tumor grade, and inhibits tumor cell growth in vitro and in vivo.
Ardini E; Agresti R; Tagliabue E; Greco M; Aiello P; Yang LT; Ménard S; Sap J
Oncogene; 2000 Oct; 19(43):4979-87. PubMed ID: 11042685
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory tyrosine protein kinase p50csk is associated with protein-tyrosine phosphatase PTP-PEST in hemopoietic and non-hemopoietic cells.
Davidson D; Cloutier JF; Gregorieff A; Veillette A
J Biol Chem; 1997 Sep; 272(37):23455-62. PubMed ID: 9287362
[TBL] [Abstract][Full Text] [Related]
35. Catalytically active membrane-distal phosphatase domain of receptor protein-tyrosine phosphatase alpha is required for Src activation.
Vacaru AM; den Hertog J
FEBS J; 2010 Mar; 277(6):1562-70. PubMed ID: 20158519
[TBL] [Abstract][Full Text] [Related]
36. Activation of Src and transformation by an RPTPα splice mutant found in human tumours.
Huang J; Yao L; Xu R; Wu H; Wang M; White BS; Shalloway D; Zheng X
EMBO J; 2011 Jul; 30(15):3200-11. PubMed ID: 21725282
[TBL] [Abstract][Full Text] [Related]
37. Intramolecular interactions between the juxtamembrane domain and phosphatase domains of receptor protein-tyrosine phosphatase RPTPmu. Regulation of catalytic activity.
Feiken E; van Etten I; Gebbink MF; Moolenaar WH; Zondag GC
J Biol Chem; 2000 May; 275(20):15350-6. PubMed ID: 10809770
[TBL] [Abstract][Full Text] [Related]
38. RPTPalpha is essential for NCAM-mediated p59fyn activation and neurite elongation.
Bodrikov V; Leshchyns'ka I; Sytnyk V; Overvoorde J; den Hertog J; Schachner M
J Cell Biol; 2005 Jan; 168(1):127-39. PubMed ID: 15623578
[TBL] [Abstract][Full Text] [Related]
39. Activation of c-Src and Fyn kinases by protein-tyrosine phosphatase RPTPalpha is substrate-specific and compatible with lipid raft localization.
Vacaresse N; Møller B; Danielsen EM; Okada M; Sap J
J Biol Chem; 2008 Dec; 283(51):35815-24. PubMed ID: 18948260
[TBL] [Abstract][Full Text] [Related]
40. Regulation of receptor protein-tyrosine phosphatase dimerization.
van der Wijk T; Blanchetot C; den Hertog J
Methods; 2005 Jan; 35(1):73-9. PubMed ID: 15588988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
